🚨 Once hailed as a beacon of hope against COVID-19, Remdesivir's past and present tell a more troubling story. In this episode of Effects on the Side, we delve into: The drug's alarming 53% mortality rate in Ebola trials. Its rapid endorsement during the pandemic despite questionable efficacy. Investigations into financial ties influencing its promotion. The ethical implications of prioritizing profit over patient safety. 🔎 Join us as we uncover the complex web behind Remdesivir and what it means for future medical interventions. 🎙️ Listen now on Effects on the Side.
About the podcast
Ever watched a pharmaceutical commercial and wondered, Are the side effects really worth it? Welcome to Effects on the Side, the podcast that takes a deep dive into the world of prescription drug commercials in the USA. Tune in, and let’s uncover the real story behind the side effects.
Share this episode
Share with friends and family